Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea.

Background: Facial erythema is a frequent and often distressing complaint of patients with rosacea. Treatment of facial erythema with botulinum toxin has previously been proposed and reported. However, the current literature has mixed results.